These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 33163393)

  • 1. The Potential Gut Microbiota-Mediated Treatment Options for Liver Cancer.
    Zhang C; Yang M; Ericsson AC
    Front Oncol; 2020; 10():524205. PubMed ID: 33163393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota and Hepatocellular Carcinoma.
    Tao X; Wang N; Qin W
    Gastrointest Tumors; 2015 May; 2(1):33-40. PubMed ID: 26673641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Gut Microbiome and Hepatocellular Carcinoma: Implications for Early Diagnostic Biomarkers and Novel Therapies.
    Kang Y; Cai Y; Yang Y
    Liver Cancer; 2022 Apr; 11(2):113-125. PubMed ID: 35634424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy.
    Wan MLY; El-Nezami H
    Hepatobiliary Surg Nutr; 2018 Feb; 7(1):11-20. PubMed ID: 29531939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the Gut Microbiome to Improve Clinical Outcomes in Hepatocellular Carcinoma.
    Shen S; Khatiwada S; Behary J; Kim R; Zekry A
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota mediated molecular events and therapy in liver diseases.
    Qi X; Yang M; Stenberg J; Dey R; Fogwe L; Alam MS; Kimchi ET; Staveley-O'Carroll KF; Li G
    World J Gastroenterol; 2020 Dec; 26(48):7603-7618. PubMed ID: 33505139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular Carcinoma: How the Gut Microbiota Contributes to Pathogenesis, Diagnosis, and Therapy.
    Luo W; Guo S; Zhou Y; Zhao J; Wang M; Sang L; Chang B; Wang B
    Front Microbiol; 2022; 13():873160. PubMed ID: 35572649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota and immune system in liver cancer: Promising therapeutic implication from development to treatment.
    Bartolini I; Risaliti M; Tucci R; Muiesan P; Ringressi MN; Taddei A; Amedei A
    World J Gastrointest Oncol; 2021 Nov; 13(11):1616-1631. PubMed ID: 34853639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiota-Associated Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Cancer: A Review.
    Chen YH; Wu WK; Wu MS
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential tactics with certain gut microbiota for the treatment of unresectable hepatocellular carcinoma.
    Yoshikawa S; Taniguchi K; Sawamura H; Ikeda Y; Asai T; Tsuji A; Matsuda S
    Explor Target Antitumor Ther; 2023; 4(4):556-568. PubMed ID: 37720344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma.
    Yu Q; Wu L; Ji J; Feng J; Dai W; Li J; Wu J; Guo C
    J Hepatocell Carcinoma; 2020; 7():271-288. PubMed ID: 33150145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease.
    Ponziani FR; Bhoori S; Castelli C; Putignani L; Rivoltini L; Del Chierico F; Sanguinetti M; Morelli D; Paroni Sterbini F; Petito V; Reddel S; Calvani R; Camisaschi C; Picca A; Tuccitto A; Gasbarrini A; Pompili M; Mazzaferro V
    Hepatology; 2019 Jan; 69(1):107-120. PubMed ID: 29665135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Gut Microbiota in Hepatocarcinogenesis.
    Gupta H; Youn GS; Shin MJ; Suk KT
    Microorganisms; 2019 May; 7(5):. PubMed ID: 31060311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Gut Microbiota: How Does It Influence the Development and Progression of Liver Diseases.
    Kanmani P; Suganya K; Kim H
    Biomedicines; 2020 Nov; 8(11):. PubMed ID: 33207562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies.
    Meroni M; Longo M; Dongiovanni P
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31689910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment.
    Spanu D; Pretta A; Lai E; Persano M; Donisi C; Mariani S; Dubois M; Migliari M; Saba G; Ziranu P; Pusceddu V; Puzzoni M; Astara G; Scartozzi M
    World J Hepatol; 2022 Jul; 14(7):1319-1332. PubMed ID: 36158925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis.
    Jiang JW; Chen XH; Ren Z; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):19-27. PubMed ID: 30527903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota: A new piece in understanding hepatocarcinogenesis.
    Zhou A; Tang L; Zeng S; Lei Y; Yang S; Tang B
    Cancer Lett; 2020 Apr; 474():15-22. PubMed ID: 31917160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of gut microbiota in liver disease development and treatment.
    Wang L; Wan YY
    Liver Res; 2019 Mar; 3(1):3-18. PubMed ID: 32461811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.